David G. Maloney MD, PhD

David Maloney, M.D., Ph.D., is a board-certified physician at SCCA, a member in the Clinical Research Division at Fred Hutchinson Cancer Research Center and a UW professor of Medicine and Oncology.

Dr. Maloney applies the latest research on new treatments when treating his patients for chronic lymphocytic leukemia, non-Hodgkin's lymphoma, and multiple myeloma. He hopes he will continue to see improvement in cancer treatment. He strives to create active partnerships with his patients to achieve the best possible outcomes.

Dr. Maloney earned his M.D. and Ph.D. at Stanford. He is the SCCA lead investigator for the following clinical trials: Autologous Stem Cell Transplant Followed By Donor Stem Cell Transplant In Treating Patients With Relapsed or Refractory Lymphoma, Ofatumumab vs. Rituximab for Relapsed Follicular Lymphoma and Immunotherapy for Advanced CD19+ Chronic Lymphocytic Leukemia and Non-Hodgkin Lymphoma.